Citation: Am. Demattos et al., PHARMACOLOGY OF IMMUNOSUPPRESSIVE MEDICATIONS USED IN RENAL DISEASES AND TRANSPLANTATION, American journal of kidney diseases, 28(5), 1996, pp. 631-667
Citation: Wm. Bennett et al., THE RENAL EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - SUMMARY AND RECOMMENDATIONS, American journal of kidney diseases, 28(1), 1996, pp. 56-62
Authors:
HENRICH WL
AGODOA LE
BARRETT B
BENNETT WM
BLANTZ RC
BUCKALEW VM
DAGATI VD
DEBROE ME
DUGGIN GG
EKNOYAN G
ELSEVIERS MM
GOMEZ RA
MATZKE GR
PORTER GA
SABATINI S
STOFF JS
STRIKER GE
WINCHESTER JF
Citation: Wl. Henrich et al., ANALGESICS AND THE KIDNEY - SUMMARY AND RECOMMENDATIONS TO THE SCIENTIFIC ADVISORY BOARD OF THE NATIONAL-KIDNEY-FOUNDATION FROM AN AD HOC COMMITTEE OF THE NATIONAL-KIDNEY-FOUNDATION, American journal of kidney diseases, 27(1), 1996, pp. 162-165
Citation: Wm. Bennett, ACADEMIC PHYSICIANS, CLINICAL INVESTIGATORS, AND MANAGED CARE - WHITHER HIPPOCRATES, Western journal of medicine, 165(4), 1996, pp. 241-244
Authors:
PICHLER RH
HUGO C
SHANKLAND SJ
REED MJ
BASSUK JA
ANDOH TF
LOMBARDI DM
SCHWARTZ SM
BENNETT WM
ALPERS CE
SAGE EH
JOHNSON RJ
COUSER WG
Citation: Rh. Pichler et al., SPARC IS EXPRESSED IN RENAL INTERSTITIAL FIBROSIS AND IN RENAL VASCULAR INJURY, Kidney international, 50(6), 1996, pp. 1978-1989
Authors:
SHIHAB FS
ANDOH TF
TANNER AM
NOBLE NA
BORDER WA
FRANCESCHINI N
BENNETT WM
Citation: Fs. Shihab et al., ROLE OF TRANSFORMING GROWTH-FACTOR-BETA-1 IN EXPERIMENTAL CHRONIC CYCLOSPORINE NEPHROPATHY, Kidney international, 49(4), 1996, pp. 1141-1151
Authors:
ANDOH TF
LINDSLEY J
FRANCESCHINI N
BENNETT WM
Citation: Tf. Andoh et al., SYNERGISTIC EFFECTS OF CYCLOSPORINE AND RAPAMYCIN IN A CHRONIC NEPHROTOXICITY MODEL, Transplantation, 62(3), 1996, pp. 311-316
Citation: Mp. Gardner et al., CLINICALLY RELEVANT DOSES AND BLOOD-LEVELS PRODUCE EXPERIMENTAL CYCLOSPORINE NEPHROTOXICITY WHEN COMBINED WITH NITRIC-OXIDE INHIBITION, Transplantation, 61(10), 1996, pp. 1506-1512
Citation: Lj. Brunner et al., SELECTIVE SUPPRESSION OF RAT HEPATIC-MICROSOMAL ACTIVITY DURING CHRONIC CYCLOSPORINE NEPHROTOXICITY, The Journal of pharmacology and experimental therapeutics, 277(3), 1996, pp. 1710-1718
Authors:
WALKER KW
WILSON RA
NORMAN DJ
BENNETT WM
BARRY JM
Citation: Kw. Walker et al., CAN SPECT THALLIUM EFFECTIVELY RISK STRATIFY RENAL-TRANSPLANT CANDIDATES WITH CLINICAL RISK-FACTORS FOR HEART-DISEASE - VALIDATION OF AN ALGORITHM FOR PREDICTING CARDIAC EVENTS, Circulation, 94(8), 1996, pp. 341-341
Authors:
PICHLER RH
FRANCESCHINI N
YOUNG BA
HUGO C
ANDOH TF
BURDMANN EA
SHANKLAND SJ
ALPERS CE
BENNETT WM
COUSER WG
JOHNSON RJ
Citation: Rh. Pichler et al., PATHOGENESIS OF CYCLOSPORINE NEPHROPATHY - ROLES OF ANGIOTENSIN-II AND OSTEOPONTIN, Journal of the American Society of Nephrology, 6(4), 1995, pp. 1186-1196
Citation: Ll. Woods et al., NEPHROTOXICITY OF SUSTAINED INFUSIONS OF POLYMYXIN-B (PMB), Journal of the American Society of Nephrology, 6(3), 1995, pp. 480-480
Citation: Tf. Andoh et al., CHRONIC RENIN-ANGIOTENSIN SYSTEM (RAS) BLOCKADE IMPAIRS RENIN RELEASEAND REDUCES PLASMA-RENIN ACTIVITY (PRA) IN SODIUM-DEPLETED RATS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 730-730
Authors:
PICHLER RH
HUGO C
REED MJ
ALPERS CE
ANDOH TF
BASSUK JA
LOMBARDI DM
SCHWARTZ SM
SAGE EH
BENNETT WM
COUSER WG
JOHNSON RJ
Citation: Rh. Pichler et al., SPARC IS EXPRESSED IN AREAS OF TUBULOINTERSTITIAL AND VASCULAR INJURYIN EXPERIMENTAL-MODELS OF RENAL-DISEASE, Journal of the American Society of Nephrology, 6(3), 1995, pp. 907-907
Citation: Tf. Andoh et al., ANGIOTENSIN-II MEDIATES ARTERIOLOPATHY IN CHRONIC CYCLOSPORINE (CSA) NEPHROTOXICITY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 994-994
Authors:
BURDMANN EA
ANDOH TF
PRADO EAB
FRANCESCHINI N
FUJIHARA C
ZATZ R
BENNETT WM
Citation: Ea. Burdmann et al., RENAL, IMMUNOSUPPRESSIVE AND PHARMACOKINETIC EFFECTS OF THE SUBSTITUTION OF INTRALIPID (LIP) FOR CREMOPHOR (CRE) AS VEHICLE FOR PARENTERAL CYCLOSPORINE (CSA) ADMINISTRATION, Journal of the American Society of Nephrology, 6(3), 1995, pp. 995-995
Citation: Mp. Gardner et al., DIETARY L-ARGININE SUPPLEMENTATION REDUCES THE FUNCTIONAL AND STRUCTURAL MANIFESTATIONS OF CHRONIC CYCLOSPORINE (CSA) NEPHROTOXICITY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 997-997